Skip to main content
. Author manuscript; available in PMC: 2017 Jun 17.
Published in final edited form as: Mol Imaging Biol. 2016 Apr;18(2):209–218. doi: 10.1007/s11307-015-0878-9

Figure 2.

Figure 2

A.) Fluorescence overlay images of KB flank tumors after varying doses of systemically injected EC17 at several different time points after injection (8hr time point not shown). B.) EC17 injection resulted in peak tumor tumor-to-background ratios (TBR) 2 hours after injection. No significant increase in TBR was seen at doses higher than 0.1 mg/kg.